Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-23-295562
Filing Date
2023-12-14
Accepted
2023-12-14 17:04:35
Documents
15
Period of Report
2023-12-14
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d612444d8ka.htm   iXBRL 8-K/A 35289
2 EX-99.1 d612444dex991.htm EX-99.1 18445
7 GRAPHIC g612444g1214092257748.jpg GRAPHIC 2593
  Complete submission text file 0001193125-23-295562.txt   224786

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pfe-20231214.xsd EX-101.SCH 3869
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pfe-20231214_def.xml EX-101.DEF 13627
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pfe-20231214_lab.xml EX-101.LAB 22565
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pfe-20231214_pre.xml EX-101.PRE 14594
9 EXTRACTED XBRL INSTANCE DOCUMENT d612444d8ka_htm.xml XML 5751
Mailing Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192
Business Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192 2127332323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

EIN.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-03619 | Film No.: 231487826
SIC: 2834 Pharmaceutical Preparations